Abstract
In Chap. 13, electrospinning has been introduced as a strategy to manipulate the physical properties of a therapeutics-loaded system and to enhance the versatility of drug delivery. In the remaining chapters in Section V, the use of chemical means to manipulate the surface properties of a carrier for more effective systemic drug delivery will be discussed. As a matter of fact, a therapeutic agent must stay in the body as long as it is needed to reach the intended site of action in order to elicit a therapeutic response. To extend the blood retention time of an agent, one commonly used strategy is surface modification. In this chapter, we will first discuss the principles of clearance of particulate drug delivery systems from the body by the mononuclear phagocyte system (MPS), followed by a discussion of the possible use of polymers as modifiers of the surface properties of the particulate systems for enhanced performance in systemic drug delivery. Finally, the applications of surface-modified particulates in non-MPS targeting, including cancer chemotherapy and delivery across the blood–brain barrier, will also be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abe Y et al (1996) P-glycoprotein mediated acquired multidrug resistance of human lung cancer cells in vivo. Br J Cancer 74:1929–1934
Abuchowski A et al (1977) Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 252:3578–3581
Al Jamal WT, Kostarelos K (2011) Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Acc Chem Res 44:1094–1104
Allemann E et al (1995) PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluro zinc phthalocyanine to EMT-6 mouse mammary tumours. J Pharm Pharmacol 47:382–387
Allemann E, Gurny R, Doelker E (1993) Drug loaded nanoparticles - Preparation methods and drug targeting issues. Eur J Pharm Biopharm 39:173–191
Allen TM (1989) Stealth liposomes: avoiding reticuloendothelial uptake in liposomes. In: Lopez-Bernstein G, Fidler IJ (eds) Liposomess in the therapy of infectious diseases and cancer. Alan R. Liss, New York, p 405
Allen TM et al (1991) Uptake of liposomes by cultured mouse bone marrow macrophages: Influence of liposome composition and size. Biochem Biophys Acta 1061:56–64
Allen TM (1994) The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Deliv Rev 13:285–309
Allen TM, Chonn A (1987) Large unilameller liposomes with low uptake into reticuloendothelial system. FEBS Lett 223:42–46
Alyautdin R et al (1995) Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80 coated poly(butyl cyanoacrylate) nanoparticles. Eur J Pharm Biopharm 41:44–48
Amiji M, Park K (1992) Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers. Biomaterials 13:682–692
Amiji M, Park K (1994) Surface modification of polymeric biomaterials with poly(ethylene oxide). In: Shalaby SW et al (eds) Polymers of biological and biomedical significance. American Chemical Society, Washington DC, pp 135–146
Andrade JD (1976) Interfacial phenomena and biomaterials. Med Instrum 7:110–120
Andrade JD (1987) Surfaces and blood compatibility. Trans Amer Soc Artif Intern Organs 7:75–76
Andrade JD, Halady V (1986) Protein adsorption and materials biocompatibility. Adv Polym Sci 79:1–63
Artursson P, Laakso T, Edman P (1983) Acrylic microspheres in vivo: Blood elimination kinetics and organ distribution of microparticles with different surface characteristics. J Pharm Sci 72:1415–1420
Astier A, Doat B, Ferrer MJ et al (1988) Enhancement of adriamycin antitumor activity by its binding with an intercellular sustained release form, polymethacrylate nanospheres, in U-937 cells. Cancer Res 48:1835–1841
Atkinson JP, Frank MM (1974) Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J Clin Invest 54:339–348
Baggetto LG (1997) Non P-glycoprotein novel proteins involved in human cancer multidrug resistance. Bull Cancer 84:385–390
Bailon P, Berthold W (1998) Polyethylene glycol—conjugated pharmaceutical proteins. Pharm Sci Technol Today 1:352–356
Ban T (1992) Pleiotropic, multidrug-resistance phenotype and P-glycoprotein: a review. Chemotherapy 38:191–196
Barrand MA, Bagrij T, Neo SY (1997) Multidrug resistance associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion. Gen Pharmacol 26:639–645
Barui AK et al (2020) Cancer-targeted nanomedicine: overcoming the barrier of the protein corona. Adv Ther 3:1900124
BASF Performance Chemicals, Pluronic and Tetronic Surfactants. 2020 [cited 2020 Jan 10]. Available from: https://www.basf.com/hk/en.html
Blume G, Cevc G (1993) Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta 1146:157–168
Blunk T et al (1993a) Differential adsorption: Effect of plasma protein adsorption patterns on organ distribution of colloidal drug carriers. Proc Int Symp Control Rel Bioact Mater 20:256–257
Blunk T et al (1993b) Differential adsorption: effect of plasma protein adsorption patterns on organ distribution of colloidal drug carriers. Proc Int Symp Cont Rel Bioact Mater 20:256–257
Borchard G et al (1994) Uptake of surfactant coated poly(methyl methacrylate) nanoparticles by bovine brain microvessel endothelial cell monolayers. Int J Pharm 110:29–35
Brasseur F, Couvreur P, Kante B et al (1980) Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: Increased efficiency against an experimental tumor. Eur J Cancer 16:1441–1445
Brown DL, Lachmann PJ, Dacie JV (1970) The in vivo behaviour of complement coated red cells: Studies in C6 deficient, C3-depleted and normal rabbits. Clin Exp Immunol 7:401–422
Cao et al. ZT (2020) Protein binding affinity of polymeric nanoparticles as a direct indicator of their pharmacokinetics. ACS Nano
Cerrai P, Tricoli M (1993) Block copolymers from L-lactide and poly(ethylene glycol) through a non-catalyzed route. Makromol Chem Rapid Commun 14:529–538
Champion JA, Mitragotri S (2006) Role of target geometry in phagocytosis. Proc Nat Acad Sci 103(13):4930–4934
Champion JA, Mitragotri S (2009) Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 26(1):244–249
Chin TH, Nyilas E, Turcotte LR (1978) Microcalorimetric and electrophoretic studies of protein sorption. Trans Am Soc Artif Intern Organs 24:389–402
Cho EC et al (2010) The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small 6:517–522
Churchill JR, Hutchinson FG (1986) Biodegradable amphipathic copolymers, EP
Coombes AGA et al (1994) Resorbable polymeric microspheres for drug delivery—production and simultaneous surface modification using PEO-PPO surfactants. Biomaterials 15:673–680
Couvreur P, Kante B, Grislain L et al (1982) Toxicity of polyalkylcyanoacrylate nanoparticles II: doxorubicin nanoparticles. J Pharm Sci 71:790–792
De Jaeghere F et al (1999) Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles : Influence on physical stability and in vitro cell uptake. Pharm Res 16:859–866
Delgado C, Francis GE, Fisher D (1992) The uses and properties of PEG-linked proteins. Crit Rev Ther Drug Carrier Syst 9:249–304
De Magalhães JP, Stevens M, Thornton D (2017) The business of anti-aging science. Trends Biotechnol 35:1062–1073
Deng XM et al (1990) Synthesis and characterization of block copolymers from D, L-lactide and poly(ethylene glycol) with stannous chloride. J Polym Sci B 28:411–416
Devine DV et al (1994) Liposome complement interaction in rat serum: Implications for liposome survival studies. Biochim Biophys Acta 1191:43–51
Diederichs JE et al (1996) Adsorption of plasma components on liposomes of different size. Eur J Pharm Biopharm 42:37S
Dunn SE et al (1994a) Biodistribution studies investigating poly(lactide-co-glycolide) nanospheres surface modified by novel biodegradable copolymers. Proc Int Symp Control Rel Bioact Mater 21:210–211
Dunn SE et al (1994b) Biodistribution studies investigating poly(lactide-co-glycolide) nanospheres surface modified by novel biodegradable copolymers. Proc Intern Symp Control Rel Bioact Mater 21:210–211
Ehlenberger AG, Nussenzweig V (1977) The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med 145:357–371
Elgert KD (1996) Immunology: understanding the immune system. Wiley-Liss Inc., New York
Elias DR et al (2013) Effect of ligand density, receptor density, and nanoparticle size on cell targeting. Nanomedicine 9:194–201
Elkin SR, Bendris N, Reis CR, Zhou Y, Xie Y, Huffman KE, Minna JD, Schmid SL (2015) A systematic analysis reveals heterogeneous changes in the endocytic activities of cancer cells. Cancer Res 75(21):4640–4650
Erickson TB et al (1996) Acute renal toxicity after ingestion of Lava light liquid. Ann Emerg Med 27:781–784
Fang Y et al (2017) Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery. Drug Deliv 24:22–32
Fernandes M et al (2016) Systematic analysis of the gerontome reveals links between aging and age-related diseases. Hum Mol Genet 25:4804–4818
Filion MC, Philips NC (1997) Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta 1329:345–356
Ford JM, Hait WN (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42:155–199
Gabizon A et al (1994) Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54:987–992
Gabizon A, Papahadjopoulos D (1992) The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochim Biophys Acta 1103:94–100
Gilding DK, Reed AM (1979) Biodegradable polymers for use in surgery-polyglycolic/poly(lactic acid) homo- and copolymers. Polymer 20:1459–1464
Gipps EM et al (1988) Distribution of polyhexylcyanoacrylate nanoparticles in nude mice over extended times and after repeated injection. J Pharm Sci 77:208–209
Gordon S (1987) Mononuclear phagocyte system and tissue homeostasis. In: Weatherhall DJ, Ledingham JGG, Warrell DA (eds) Oxford textbook of medicine. Oxford University Press, Oxford
Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385–427
Gottesman MM et al (1995) Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 29:607–649
Gref R et al (1994) Biodegradable long-circulating polymeric nanospheres. Science 263:1600–1603
Griveau A et al (2018) Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes. Aging Cell 17:e12835
Gupta PK (1990) Drug targeting in cancer chemotherapy: a clinical perspective. J Pharm Sci 79:949–962
Hagan SA et al (1995) PLA-PEG micelles—a novel drug delivery system. Proc Int Symp Cont Rel Bioact Mater 22:194–195
Harper GR et al (1991) Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat kupffer cells in vitro. Biomaterials 12:695–699
Harris J (1985) Laboratory synthesis of polyethylene glycol derivatives. J Macromol Sci Rev Macromol Chem Phys 25:325–373
Hatakeyama H, Akita H, Harashima H (2013) The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors. Biol Pharm Bull 36:892–899
Hawley AE, Illum L, Davis SS (1997) Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res 14:657–661
Haynes CA, Norde W (1995) Structures and stabilities of adsorbed proteins. J Colloid Interface Sci 169:313–328
Hollo Z et al (1996) Transport properties of the multidrug resistance associated protein (MRP) in human tumor cells. FEBS Let 383:99–104
Ibrahim MX et al (2013) Targeting isoprenylcysteine methylation ameliorates disease in a mouse model of progeria. Science 340:1330–1333
Illum L, Davis SS (1982) The targeting of drugs parenterally by the use of microspheres. Bull Parenter Drug Assoc 36:242–248
Illum L, Davis SS (1983) Effect if the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration. J Pharm Sci 72:1086–1089
Illum L, Davis SS (1984) The organ uptake of intravenously administered colloidal particles can be altered using nonionic surfactant (poloxamer 338). FEBS Lett 167:79–82
Illum L, Hunneyball IM, Davis SS (1986) The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages. Int J Pharm. 29:53–65
Illum L et al (1987) Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. Biomaterials 8:113–117
Ishida T et al (2007) PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. J Control Release 122:349–355
Izquierdo MA et al (1996) Relationship of LRP human major vault protein to in vitro and clinical resistance to anticancer drugs. Cytotechnology 19:191–197
Jain RK (1987) Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6:559–593
Jedlitschky G et al (1996) Transport of glutathione, glucuronate and sulfate conjugates by the MRP gene-encoded export pump. Cancer Res 56:988–994
Jeon SI, Andrade JD (1991) Protein-surface interactions in the presence of polyethylene oxide II Effect of protein size. J Colloid Interface Sci 142:159–166
Jeon SI et al (1991) Protein-surface interactions in the presence of polyethylene oxide, I Simplified theory. J Colloid Interface Sci 142:149–158
Jiang W et al (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3:145–150
Juliano RL, Stemp D (1975) The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem Biophys Commun 63:651–658
Kamps JA et al (1994) Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. Proc Natl Acad Sci 94:11681–11685
Kato T et al (1981) Quasielastic light scattering measurements of polystyrene lattices and conformation of poly(oxyethylene) adsorbed on the lattices. Polymer J 13:1037–1043
Kawaguchi H et al (1985) Interaction between proteins and latex particles having different surface structures. Colloids Surf 13:295–311
Kilbanov AL et al (1990) Amphipathic polyethylene glycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235–237
Kim SW (1974) Role of carbohydrates in platelet adhesion. J Biomed Mater Res 8:393–399
Kissel T et al (1994) Release properties of macromolecules from microspheres of a ABA triblock copolymer consisting of poly(lactic-co-glycolic acid) and polyoxyethylene. Proc Intern Symp Control Rel Bioact Mater 21:286–287
Klein J (1986) Surface interactions with adsorbed macromolecules. J Colloid Interface Sci 111:305–313
Koosha F et al (1989) Poly-hydoxybutyrate as a drug carrier. CRC Crit Rev Ther Drug Carrier Syst 6:117–130
Kreuter J (1983) Evaluation of nanoparticles as drug delivery systems III: materials, stability, toxicity, possibilities of targeting, and use. Pharm Acta Helv 58:242–250
Kreuter J, Hartmann HR (1983) Comparative study on the cytotostatic effects and the tissue distribution of 5-flurouracil in a free form and bound to polybutylcyanoacrylate nanoparticles in sarcoma 180-bearing mice. Oncology 40:363–366
Kreuter J et al (1995) Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res 674:171–174
Kreuter J et al (1997) Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant coated nanoparticles. J Control Release 49:81–87
Kricheldorf H, Meier-Haack J (1993) Polylactones, 22a) ABA triblock copolymers of L-lactic acid and poly(ethylene glycol). Makromol Chem 194:715–725
Krishnan A, Fitz CM, Andritsh I (1997) Drug retention, efflux, and resistance in tumor cells. Cytometry 229:279–285
Kruh GD et al (1995) Expression pattern of MRP in human tissues and adult solid tumor cell lines. J Natl Cancer Inst 87:1256–1258
Kubiak C et al (1989) Increased cytotoxicity of nanoparticle-carried adriamycin in vitro and potentiation by verapamil and amioderone. Biomaterials 10:553–556
Laakso T, Artursson P, Sjoholm I (1986) Biodegradable microspheres IV: factors affecting the distribution and degradation of polyacryl starch microparticles. J Pharm Sci 75:962–967
Labarre D et al (1994) Complement activation by nanoparticulate carriers. Proc Intern Symp Control Rel Bioact Mater 21:91–92
Lacasse FX, Hildgen P, McMullen JN (1998) Surface and morphology of spray-dried pegylated PLA microspheres. Int J Pharm 174:101–109
Lacasse FX et al (1988) Influence of surface properties at biodegradable microspheres surfaces: effects on plasma protein adsorption and phagocytosis. Pharm Res 15:312–317
Lacasse FX et al (1998) Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis. Pharm Res 15:312–317
Lai WF (2013) Nucleic acid delivery: roles in biogerontological interventions. Ageing Res Rev 12:310–315
Lai WF, He ZD (2016) Design and fabrication of hydrogel-based nanoparticulate systems for in vivo drug delivery. J Control Release 243:269–282
Lai WF, Rogach AL, Wong WT (2017) Molecular design of upconversion nanoparticles for gene delivery Chem Sci 8:7339–7358
Lai WF, Shum HC (2016) A stimuli-responsive nanoparticulate system using poly(ethylenimine)-graft-polysorbate for controlled protein release. Nanoscale 8:517–528
Lai WF, Wong WT (2018) Design of polymeric gene carriers for effective intracellular delivery. Trends Biotechnol 36:713–728
Lai WF, Rogach AL, Wong WT (2017) Chemistry and engineering of cyclodextrins for molecular imaging. Chem Soc Rev 46:6379–6419
Lasic DD et al (1991) Sterically stabilized liposomes - A hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta 1070:187–192
Law SK, Levine RP (1977) Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci 74:2701–2705
Leininger RI (1972) Polymers as surgical implants. CRC Crit Rev Bioeng 1:333–381
Leroux JC et al (1995) An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D, L-lactic acid) nanoparticles by human monocytes. Life Sci 57:695–703
Lherm C et al. (1992) Alkyl cyanoacrylate drug carriers. II: cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length. Int J Pharm 84:13–22
Li X et al (2000) Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres. J Control Release 68:41–52
Ling V (1987) Multidrug resistance and P-glycoprotein expression. Ann NY Acad Sci 507:7–8
Ling V (1997) Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40:3–8
Lu F et al (2009) Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5:1408–1413
Lundstrom I, Elwing H (1990) Simple kinetic models for protein exchange reactions on solid surfaces. J Colloid Interface Sci 136:68–84
Maaben S et al. (1993) Comparison of cytotoxicity between polyester nanoparticles and solid-lipid nanoparticles (SLN). Proc Intern Symp Control Rel Bioact Mater 20:490–491
Mackie AR, Mingins J, Dann R (1991) Preliminary studies of β-lactoglobulin adsorbed on polystyrene latex. In: Dickinson E (ed) Food Polymers Gels and Colloids. Royal Soc. Chemistry, Cambridge, UK, pp 96–112
Maste M et al (1994) Synthesis and characterization of a short-haired poly(ethylene oxide) grafted polystyrene latex. Colloids Surf A Physicochem Eng Asp 83:255–260
Medzhitov R, Janeway JCA (1997) Innate immunity: Impact on the adaptive immune response. Curr Opin Immunol. 9:4–9
Metchnikoff E (1891) Lectures on the comparative pathology of inflammation. In: Kegan Paul, Trench, Traubner & Co., London
Moghimi SM et al (1993a) Coating particles with a block co-polymer (poloxamine-908) suppress opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta 1179:157–165
Moghimi S et al (1993b) Coating particles with a block copolymer (poloxamine 908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta 1179:157–165
Monkkonen J et al (1994) Effects of liposome surface charge and size on the intracellular delivery of clodronate and gallium in vitro. Int J Pharm. 107:189–197
Monnier A et al (2016) Preparation and characterization of biodegradable polyhydroxybutyrate-co-hydroxyvalerate/polyethylene glycol-based microspheres. Int J Pharm 513:49–61
Moretti J, Blander JM (2014) Insights into phagocytosis-coupled activation of pattern recognition receptors and inflammasomes. Curr Opin Immunol 26:100–110
Mori A et al (1991) Influence of steric barrier activity of amphipathic poly(ethylene glycol) and ganglioside GM1 on the circulation time of liposomes on the target binding of immunoliposomes in vivo. FEBS Lett 284:263–266
Muller BG, Kissel T (1993) Camouflage nanospheres: a new approach to bypassing phagocytic blood clearance by surface modified particulate carriers. Pharm Pharmacol Lett 3:67–70
Muller RH, Wallis KH (1993) Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908. Int J Pharm 89:25–31
Muller RH et al (1996) Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target 4:161–170
Naper DH (1983) Polymeric stabilization of colloidal dispersions. Academic Press, New York
Natarajan K, Baer MR, Ross DD (2015) Role of breast cancer resistance protein (BCRP, ABCG2) in cancer outcomes and drug resistance. In: Resistance to targeted ABC transporters in cancer, pp 53–88, Springer, Cham
Nemati F, Dubernet C, De Verdiere AC et al (1994) Some parameters influencing cytotoxicity of free doxorubicin and doxorubicin-loaded nanoparticles in sensitive and multidrug resistant leukemic murine cells: Incubation time, number of nanoparticles per cell. Int J Pharm 102:55–62
Neumann AW et al (1979) Surface thermodynamics of leukocyte and platelet adhesion to polymer surfaces. Cell Biophys. 1:79–92
Nguyen BJVH (2017) Protein corona: A new approach for nanomedicine design. Int J Nanomed 12:3137–3151
Nyilas E, Ward RS (1977) Development of blood compatible elastomers. J Biomed Mater Res 8:69–84
Oss CJV (1978) Phagocytosis as a surface phenomenon. Ann Rev Microbiol 32:19–39
Pain D et al (1984) Increased circulatory half-life of liposomes after conjugation with dextran. J Biosci 6:811–816
Papahdjopoulos D et al (1991) Sterically—stabilized liposomes—improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci 88:11460–11464
Patel HM, Moghimi SM (1990) Tissue specific serum opsonins and phagocytosis of liposomes. In: Gregoriadis G, Allison AC, Poste G (eds) Targeting of drugs 2—optimization strategies. Plenum Press, New York, p 87
Patel HM, Tuzel NS, Rymen BE (1983) Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen. Bioche. Biophys. Acta 761:142–151
Pean JM et al (1999) Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres. Pharm Res 16:1294–1299
Pelaz B et al (2015) Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake. ACS Nano 9:6996–7008
Peracchia MT et al (1994) PEG-coated nanospheres for intravenous drug delivery and targeting. Proc Int Symp Control Rel Bioact Mater 21:513–514
Peracchia MT et al (1997) Development of sterically stabilized poly(isobutyl-2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol). J Biomed Mater Res 34:317–326
Petrak K (1993) Design and properties of particulate carriers for intravascular administration. In: Rolland A (ed) Pharmaceutical particulate carriers. Marcel Dekker, New York
Piskin E et al (1995) Novel PDLLA/PEG copolymer micelles as drug carriers. J Biomater Sci Polymer Edn 7:359–373
Rejman J et al (2004) Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 377:159–169
Rice KG, Lee YC (1990) Modification of triantennary glycopeptide into probes for the asialoglycoprotein of hepatocytes. J. Biol. Chem. 265:18423–18428
Roerdink F et al (1983) Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement. Biochim Biophys Acta 734:33–39
Rogers KE, Carr BI, Tokes ZA (1983) Cell surface mediated cytotoxicity of polymer bound adriamycin against drug resistant hepatocytes. Cancer Res 43:2741–2748
Roitt I, Brostoff J, Male D (1996) Immunology. Mosby, London
Ronneberger B, Kissel T, Anderson JM (1997) Biocompatibility of ABA triblock copolymer microparticles consisting of poly(L-lactic-co-glycolic acid) A-blocks attached to central poly(oxyethylene) B-blocks in rats after intramuscular injection. Eur J Pharm Biopharm 43:19–28
Roser M, Fischer D, Kissel T (1998) Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 46:255–263
Ross DD (2000) Novel mechanisms of drug resistance in leukemia. Leukemia 14:467–473
Ross GD, Cain JA, Lachmann PJ (1985) Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin and functions as a receptor for zymozan and rabbit erythrocytes as well as a receptor for iC3b. J Immunol 134:3307–3315
Sawyer PN (1984) Surface charge and thrombosis. Ann NY Acad Sci 416:561–584
Schöttler S, Landfester K, Mailänder V (2016) Controlling the stealth effect of nanocarriers through understanding the protein corona. Angew Chem Int Ed Engl 55:8806–8815
Schwendner RA, Lagocki PA, Rahman YE (1984) The effect of charge and size on the interaction of unilameller liposomes with macrophages. Biochim Biophys Acta 772:93–101
Scott GBD, Williams HS, Marriott PM (1967) The phagocytosis of colloidal particles of different sizes. Br J Exp Path 48:411–416
Senior JH (1987) Fate and behavior of liposomes in vivo: a review of controlling factors. CRC Crit Rev Ther Drug Carrier Syst 3:123–193
Senior J et al (1991) Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol) coated vesicles. Biochem Biophys Acta 1062:77–82
Soderquist ME, Walton AG (1980) Structural changes in proteins adsorbed on polymer surfaces. J Colloid Interface Sci 75:386–397
Stevels WM et al (1995) Stereocomplex formation in ABA triblock copolymers of poly(lactide) (A) and polyethylene glycol (B). Macromol Chem Phys 196:3687–3694
Stolnik S et al (1994) Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm Res 11:1800–1808
Stossel TP et al. (1972) Quantitative studies of phagocytosis by polymorphonuclear leukocytes. Use of emulsions to measure the initial rate of phagocytosis. J Clin Invest 51:615–624
Sugibayashi K et al. (1977) Drug carrier property of albumin microspheres in chemotherapy. I. Tissue distribution of microsphere entrapped 5-flurouracil in mice. Chem Pharm Bull 25:3433–3434
Tabata Y, Ikada Y (1988) Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. J Biomed Mater Res 22:837–858
Tokes ZA, Rogers KE, Rembaum A (1982) Synthesis of adriamycin-coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity. Proc Natl Acad Sci 79:2026–2030
Torchilin VP, Papisov ML (1994a) Why do polyethylene glycol-coated liposomes circulate so long? J Liposome Res 4:725–739
Torchilin VP, Papisov MI (1994b) Hypothesis: why do polyethylene glycol-coated liposomes circulate so long? J Liposome Res 4:725–739
Torchilin VP, Trubetskoy VS (1995) Which polymers can make nanoparticulate drug carriers long circulating? Adv Drug Deli Rev 16:141–155
Tosi G, Duskey JT, Kreuter J (2020) Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier. Expert Opin Drug Delivery 17(1):23–32
Troster SD, Muller U, Kreuter J (1990a) Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants. Int J Pharm 61:85–100
Troster SD, Muller U, Kreuter J (1990b) Modification of body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants. Int J Pharm 61:85–100
Van Oss CJ, Gillman CF, Neumann AW (1975) Phagocytic engulfment and cell adhesiveness as cellular surface phenomena. Marcel Dekker, New York
Verrecchia T et al (1995) Non-Stealth (Poly(lactic acid/albumin) and stealth (poly(lactic acid—polyethylene glycol)) nanoparticles as injectable drug carriers. J Control Release 36:49–61
Vroman L (1982) Protein/suface interaction. In: Szycher M (ed) Biocompatible polymers, metals, and composites. Technomic Publishing, Lancaster
Wang M, Thanou M (2010) Targeting nanoparticles to cancer. Pharmacol Res 62:90–99
Wang X, Ishida T, Kiwada H (2007) Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. J Control Release 119:236–244
Webster R, Elliott V, Park BK, Walker D, Hankin M, Taupin P (2009) PEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals. PEGylated Protein Drugs: Basic Sci Clin Appl 127–146
WF Lai, WT Wong (2020) Roles of the actin cytoskeleton in aging and age-associated diseases. Ageing Res Rev 58:101021
Wojcieowski PW, Brash JL (1993) Fibrinogen and albumin adsorption from human blood plasma and from buffer onto chemically functionalized silica substrates. Colloid Surf B Biointerfaces 1:107–117
Woodle MC (1993) Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation. Chem Phys Lipids 64:249–262
Yamaoka T, Tabata Y, Ikada Y (1994) Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J Pharm Sci 83:601–606
Yeh MK et al (1995) Improving the delivery capacity of microparticle system using blends of poly(DL-lactide-co-glycolide) and poly(ethylene glycol). J Control Release 37:1–9
Yeh MK, Davis SS, Coombes AGA (1996) Improving protein delivery from microparticles using blends of poly(DL-lactide-co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers. Pharm Res 13:1693–1698
Yokoyama K et al (1975) Preparation of perflurodecalin emulsion, an approach to the red cell substitute. Fed Proc 34:1478–1483
Youxin L, Kissel T (1993) Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly(L-lactic acid) or poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks. J Control Release 27:247–257
Zilversmit DB, Boyd GA, Brucer M (1952) The effect of particle size on blood clearance and tissue distribution of radioactive gold colloids. J Lab Clin Med 40:255–260
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Glossary
- Adsorption
-
Adhesion of molecules from a gas, liquid, or dissolved solid to a surface.
- Amphiphilic polymers
-
Polymers possessing both hydrophilic and lipophilic properties.
- Efflux pump
-
A proteinaceous transporter localized in the cytoplasmic membrane cells.
- Graft polymer
-
A branched copolymer with one or more side chains of a homopolymer attached to the backbone of the main chain.
- Liposomes
-
Spherical vesicles having at least one lipid bilayer. Liposomes can be used as a vehicle for administration of bioactive agents.
- Macrophages
-
White blood cells that surround and kill microorganisms, remove dead cells, and stimulate the action of other immune system cells.
- Major histocompatibility complex
-
Proteins that are essential for adaptive immunity.
- Phagocytosis
-
The process by which a cell uses its plasma membrane to engulf a large particle, giving rise to an internal compartment called the phagosome.
- Stem cell
-
A cell that has the ability to develop into many different cell types, from muscle cells to brain cells.
- T cells
-
Lymphocyte immune cells that protect the body from pathogens and responsible for immunity against cancer cells.
- van der Waals attractive forces
-
Weak non-covalent, non-ionic forces between atoms or molecules.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Das, S.K., Das, N.G. (2020). Surface Modification Strategies in Enhancing Systemic Delivery Performance. In: Lai, WF. (eds) Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications. Healthy Ageing and Longevity, vol 13. Springer, Cham. https://doi.org/10.1007/978-3-030-54490-4_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-54490-4_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54489-8
Online ISBN: 978-3-030-54490-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)